Vera Therapeutics, Inc.
VERAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Vera Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Vera Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-23 · Fordyce Marshall: Larger than 98 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2026-02-23 · Fordyce Marshall: Larger than 96 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2025-11-11 · Young Joseph R: Larger than 94 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-08-14 · Fordyce Marshall: Larger than 95 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-05-16 · Young Joseph R: Larger than 97 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-04-03 · Grant Sean: Larger than 101 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-03-25 · Katabi Maha: Larger than 102 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-03-22 · Katabi Maha: Larger than all 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-03-21 · Katabi Maha: Larger than 100 of the 103 other insider sales of Class A Common Stock on file. SEC filing
- 2024-03-21 · Katabi Maha: Larger than 99 of the 103 other insider sales of Class A Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-23 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −88 | 38.43 | SEC filing |
| 2026-06-23 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −18,412 | 37.93 | SEC filing |
| 2026-05-12 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −4,281 | 37.09 | SEC filing |
| 2026-05-12 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −14,219 | 36.64 | SEC filing |
| 2026-04-14 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −900 | 45.51 | SEC filing |
| 2026-04-14 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −7,921 | 44.58 | SEC filing |
| 2026-04-14 | Fordyce Marshall · PRESIDENT AND CEO | Class A Common Stock | S — Open market or private sale | −14,130 | 43.66 | SEC filing |
| 2026-02-23 | Grant Sean · CHIEF FINANCIAL OFFICER | Class A Common Stock | S — Open market or private sale | −4,949 | 41.98 | SEC filing |
Showing 8 of 16 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-21 | Morrison Scott W · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | ENRIGHT PATRICK G · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | Cheng Andrew · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | MORRISSEY MICHAEL · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | SEIDENBERG BETH C · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | Hall Kimball · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | Oliger Christy J. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
| 2026-05-21 | Meyers James R · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +17,084 | SEC filing |
Showing 8 of 25 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.